TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28186711

Group type: EXPERIMENTAL
Intervention: High dose statin exposure (EM 1)
Number of subjects: 404129

Group type: EXPERIMENTAL
Intervention: Cumulative standardized statin dose at index date (EM 2)
Number of subjects: 404129

Group type: EXPERIMENTAL
Intervention: Cumulative standardized statin dose in the 180 days prior to index date (EM 3)
Number of subjects: 404129
Study: 26320283

Group type: EXPERIMENTAL
Intervention: L-carnitine
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 23248351

Group type: EXPERIMENTAL
Intervention: Cognitive intervention delivered by lay health educators (LHEs)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Control, weight-loss intervention
Number of subjects: 228
Study: 21239518

Group type: EXPERIMENTAL
Intervention: Vildagliptin (100 mg once daily for 13 days)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 18495031

Group type: EXPERIMENTAL
Intervention: Real moxibustion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham moxibustion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Natural course of events
Number of subjects: 0
Study: 17181082

Group type: EXPERIMENTAL
Intervention: Controlled nursing intervention focused on education and counseling
Number of subjects: 45

Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 45
Study: 14531591

Group type: EXPERIMENTAL
Intervention: Microfilled resin‐based composite (Durafill VS) with no enamel bevel
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Microfilled resin‐based composite (Durafill VS) with beveled enamel margin
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Flowable resin‐based composite (Natural Flow) with beveled enamel margin
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Flowable resin‐based composite (Natural Flow) with no enamel bevel
Number of subjects: 105
Study: 11100397

Group type: EXPERIMENTAL
Intervention: Pulse contour (PC) technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Whole-body impedance cardiography (ICG)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both methods (PC and ICG)
Number of subjects: 40
Study: 8741955

Group type: EXPERIMENTAL
Intervention: 21 mg/day nicotine skin patch for smokers
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 7 mg/day nicotine skin patch for nonsmokers
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Nicotine skin patch (both dosages)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Nicotine skin patch (smokers only)
Number of subjects: 17
Study: 1422929

Group type: EXPERIMENTAL
Intervention: Closed circuit ventilation (ELSA de Gambro ventilator)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Open circuit ventilation (Siemens 900 B ventilator)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Closed circuit ventilation
Number of subjects: 110

Group type: COMPARATOR
Intervention: Open circuit ventilation
Number of subjects: 110
Study: 3917352

Group type: EXPERIMENTAL
Intervention: CAF (cyclophosphamide, Adriamycin, and 5-fluorouracil)
Number of subjects: 0

Group type: COMPARATOR
Intervention: L-PAM (L-phenylalanine mustard)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fixed rotation of TM (triethylenethiophosphoramide) and CAF
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sequential treatment with TM followed by CAF upon failure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fixed rotation of TM and CAF
Number of subjects: 0

Group type: COMPARATOR
Intervention: Initial treatment with TM
Number of subjects: 0

Group type: COMPARATOR
Intervention: L-PAM
Number of subjects: 0
Study: 30980223

Group type: EXPERIMENTAL
Intervention: pedometer plus access to an internet‐mediated PA intervention
Number of subjects: 112

Group type: COMPARATOR
Intervention: pedometer alone
Number of subjects: 112
Study: 28661062

Group type: COMPARATOR
Intervention: Haemoglobin trigger for RBCT < 9.7 g dL-1 (arm A)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Haemoglobin trigger for RBCT < lower normal level (female: 11.5 g dL-1, male: 13.1 g dL-1) (arm B)
Number of subjects: 133
Study: 27484823

Group type: EXPERIMENTAL
Intervention: Educational intervention combining workshops, posters, testing performance feedback, and continuous support.
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Educational intervention in practices with payments for chlamydia screening prior to the intervention.
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Educational intervention in practices with 6-15 staff.
Number of subjects: 460
Study: 24553909

Group type: EXPERIMENTAL
Intervention: Ustekinumab 45 mg
Number of subjects: 927

Group type: EXPERIMENTAL
Intervention: Ustekinumab 90 mg
Number of subjects: 927

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 927

Group type: EXPERIMENTAL
Intervention: Ustekinumab (initial placebo patients starting at wk 16 or wk 24)
Number of subjects: 927
Study: 22093158

Group type: EXPERIMENTAL
Intervention: Hyaluronidase as an adjuvant to lidocaine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 20
Study: 21048970

Group type: EXPERIMENTAL
Intervention: Artesunate plus amodiaquine (AS+AQ) monthly
Number of subjects: 2227

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2227

Group type: EXPERIMENTAL
Intervention: Bimonthly sulphadoxine‐pyrimethamine (SP) or AS+AQ
Number of subjects: 2227
Study: 16954409

Group type: EXPERIMENTAL
Intervention: Follitropin alpha
Number of subjects: 241

Group type: COMPARATOR
Intervention: uFSH
Number of subjects: 241

Group type: COMPARATOR
Intervention: hMG
Number of subjects: 241
Study: 16258091

Group type: EXPERIMENTAL
Intervention: Screening using serum CA125 interpreted with the ROC algorithm; participants with normal results returned to annual screening, intermediate results had repeat CA125 testing, elevated values underwent transvaginal ultrasound (TVS).
Number of subjects: 6682

Group type: EXPERIMENTAL
Intervention: ROC algorithm screening strategy
Number of subjects: 6682
Study: 12383808

Group type: EXPERIMENTAL
Intervention: Topical 5‐fluorouracil (50 mg/ml for 5 minutes)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Topical mitomycin C (0.2 mg/ml for 2 minutes)
Number of subjects: 115
Study: 10440143

Group type: EXPERIMENTAL
Intervention: Intravenous amiodarone (1 g/day for 2 days)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 7580056

Group type: EXPERIMENTAL
Intervention: Bushen Jiangu (BSJG) capsule
Number of subjects: 34

Group type: COMPARATOR
Intervention: Calcium treatment
Number of subjects: 34
Study: 2181310

Group type: EXPERIMENTAL
Intervention: Melphalan (0.2 mg per kilogram of body weight per day for five days, repeated every four to six weeks for up to 12 cycles)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Melphalan (same regimen as above)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Intraperitoneal 32P (15 mCi) at the time of surgery
Number of subjects: 222
Study: 94381

Group type: EXPERIMENTAL
Intervention: Mexiletine
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study: 31903682

Group type: EXPERIMENTAL
Intervention: 10-20-30 training
Number of subjects: 51

Group type: COMPARATOR
Intervention: MICT
Number of subjects: 51
Study: 30483722

Group type: EXPERIMENTAL
Intervention: Comprehensive early rehabilitation for 4 weeks
Number of subjects: 326

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 326
Study: 28946522

Group type: EXPERIMENTAL
Intervention: Spinal Stabilization Exercises (SSE)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Manual Therapy (MG)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control Group (not explicitly mentioned)
Number of subjects: 113
Study: 25663642

Group type: EXPERIMENTAL
Intervention: Daily antioxidant therapy
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Antioxidant therapy in chronic ITP
Number of subjects: 78

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 78
Study: 23494477

Group type: EXPERIMENTAL
Intervention: Differential Outcomes Procedure (DOP) with three forms of consequences: (1) reinforcers given for correct choices ('+'), (2) reinforcers withdrawn for errors ('-'), (3) reinforcers given for correct choices and withdrawn for incorrect choices ('+/−')
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Differential Outcomes Procedure (DOP) with different types of reinforcers (secondary and primary reinforcers in Experiment 1; primary reinforcers alone in Experiment 2)
Number of subjects: 0
Study: 21292056

Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA) therapy consisting of eight 30- to 60-minute sessions across 4 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Treatment-as-usual (control)
Number of subjects: 50
Study: 19190819

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 46

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 46
Study: 17691365

Group type: EXPERIMENTAL
Intervention: Minimal Invasive Unilateral Technique (MIT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Classical Midline Laminotomy technique (CML)
Number of subjects: 20
Study: 15390011

Group type: EXPERIMENTAL
Intervention: Levetiracetam (titrated to 3,000 mg/day or lower maximal tolerated dose)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 11243949

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP), 0.5 mg/kg q6h for 3 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Methylprednisolone (MP), 0.5 mg/kg q6h for 3 days, then tapered and terminated on the tenth day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (3-day MP treatment)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (10-day MP treatment)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study: 9683004

Group type: EXPERIMENTAL
Intervention: 25 g oral dosage of glucose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saccharin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water
Number of subjects: 0
Study: 7516951

Group type: EXPERIMENTAL
Intervention: Interferon alpha-2a
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 60
Study: 2509688

Group type: EXPERIMENTAL
Intervention: Prolene (non-absorbable suture)
Number of subjects: 100

Group type: COMPARATOR
Intervention: PDS (absorbable suture)
Number of subjects: 100
Study: 778998

Group type: EXPERIMENTAL
Intervention: Piribedil
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Piribedil in association with L‐Dopa
Number of subjects: 17
Study: 30954561

Group type: EXPERIMENTAL
Intervention: INT20 (sitting interrupted by 2 min of walking every 20th minute)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: INT60 (sitting interrupted by 6 min of walking every hour)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: INT120 (sitting interrupted by 12 min of walking every second hour)
Number of subjects: 14

Group type: COMPARATOR
Intervention: SIT (uninterrupted sitting)
Number of subjects: 14
Study: 27654143

Group type: EXPERIMENTAL
Intervention: Food advertisements
Number of subjects: 200

Group type: COMPARATOR
Intervention: Toy advertisements
Number of subjects: 200
Study: 25588568

Group type: EXPERIMENTAL
Intervention: Preoperative intra-aortic balloon pump
Number of subjects: 625
Study: 24021325

Group type: EXPERIMENTAL
Intervention: Aegis with amorphous calcium phosphate sealant
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Delton illuminating sealant
Number of subjects: 110

Group type: COMPARATOR
Intervention: Permanent maxillary 1st molars
Number of subjects: 110
Study: 21737232

Group type: EXPERIMENTAL
Intervention: Severe protein C deficiency
Number of subjects: 775

Group type: COMPARATOR
Intervention: No severe protein C deficiency
Number of subjects: 775
Study: 19453778

Group type: EXPERIMENTAL
Intervention: P-3051 (8% ciclopirox‐medicated nail lacquer)
Number of subjects: 467

Group type: COMPARATOR
Intervention: Reference (market 8% ciclopirox nail lacquer)
Number of subjects: 467

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 467
Study: 14688692

Group type: EXPERIMENTAL
Intervention: Leukocyte-depleted terminal blood cardioplegia (LDTC)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 54
Study: 11050493

Group type: EXPERIMENTAL
Intervention: Q-switched 1064 nm Nd:YAG laser
Number of subjects: 40

Group type: COMPARATOR
Intervention: Q-switched 755 nm alexandrite laser
Number of subjects: 40
Study: 9412301

Group type: EXPERIMENTAL
Intervention: Questionnaire with numeracy scoring
Number of subjects: 500
Study: 8399011

Group type: EXPERIMENTAL
Intervention: Continuous wave Doppler studies of umbilical artery. Results immediately available to clinicians.
Number of subjects: 2289
Study: 3776819

Group type: EXPERIMENTAL
Intervention: Intracoronary streptokinase
Number of subjects: 52
Study: 31185079

Group type: EXPERIMENTAL
Intervention: Capped specimens
Number of subjects: 290

Group type: COMPARATOR
Intervention: Uncapped specimens
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: LDH levels
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Free hemoglobin concentration
Number of subjects: 290
Study: 29756308

Group type: EXPERIMENTAL
Intervention: App + Video Orientation (VG + App)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: App
Number of subjects: 291

Group type: COMPARATOR
Intervention: Oral Group (OG)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Video Orientation (VG)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: All methods (OG, VG, OG + App, VG + App)
Number of subjects: 291
Study: 26853484

Group type: EXPERIMENTAL
Intervention: 5 mg/d folate supplements
Number of subjects: 58
Study: 24990642

Group type: EXPERIMENTAL
Intervention: Strong responsibility condition (women)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Strong responsibility condition (men)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Strong SBA condition (women)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Strong SBA condition (men)
Number of subjects: 161
Study: 22767210

Group type: EXPERIMENTAL
Intervention: Laparoscopic repair (TAPP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Open repair (mesh)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Patients under 65 years
Number of subjects: 120
Study: 21226431

Group type: EXPERIMENTAL
Intervention: LMA Supreme (SLMA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: I-Gel
Number of subjects: 90
Study: 18570896

Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (healthy subjects)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (patients with chronic idiopathic diarrhea)
Number of subjects: 40
Study: 15949484

Group type: EXPERIMENTAL
Intervention: Elasticated support bandage
Number of subjects: 50

Group type: COMPARATOR
Intervention: Plaster immobilisation
Number of subjects: 50
Study: 12606903

Group type: EXPERIMENTAL
Intervention: Video system for initial training (n = 16)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Nonvideo system for initial training (n = 20)
Number of subjects: 36
Study: 11251331

Group type: EXPERIMENTAL
Intervention: 40 mg of enoxaparin administered subcutaneously
Number of subjects: 24
Study: 9081373

Group type: EXPERIMENTAL
Intervention: Cervical ultrasonography
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ultrasound fine-needle aspiration biopsy (UGFAB)
Number of subjects: 50
Study: 1855737

Group type: EXPERIMENTAL
Intervention: Bromocriptine (2.5 mg twice daily for 1 year)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 6887078

Group type: EXPERIMENTAL
Intervention: formal EMG‐feedback training
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: combined training of EMG‐feedback and progressive relaxation
Number of subjects: 18

Group type: COMPARATOR
Intervention: waiting list
Number of subjects: 18
Study: 31826368

Group type: EXPERIMENTAL
Intervention: BCAA supplementation (3.4 g) combined with muscle strengthening exercises
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (1.2 g of starch)
Number of subjects: 31
Study: 30202188

Group type: EXPERIMENTAL
Intervention: Community-coalition intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Direct technical assistance for disseminating depression care
Number of subjects: 0
Study: 26959879

Group type: EXPERIMENTAL
Intervention: Flurbiprofen (administered before skin incision and at the end of operation), n=30
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Flurbiprofen
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (group C), n=30
Number of subjects: 60
Study: 23764967

Group type: COMPARATOR
Intervention: Stratus TD‐OCT radial scan
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Spectralis HRA+OCT (radial)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Spectralis HRA+OCT (7-line raster)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Spectralis HRA+OCT (volumetric)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cirrus HD‐OCT (5-line raster)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cirrus HD‐OCT (volumetric)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall detection of exudative disease activity
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intraretinal cysts
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Subretinal fluid
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fluid in both locations
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cirrus volume
Number of subjects: 50
Study: 22490315

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study: 20368481

Group type: EXPERIMENTAL
Intervention: Foster care
Number of subjects: 136

Group type: COMPARATOR
Intervention: Institutional care as usual
Number of subjects: 136
Study: 17394653

Group type: EXPERIMENTAL
Intervention: Pretreatment intervention designed to enhance treatment motivation, decrease crack use, and prepare for treatment entry.
Number of subjects: 443

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 443
Study: 17518402

Group type: EXPERIMENTAL
Intervention: Computer assisted pedicle screw placement
Number of subjects: 10
Study: 14620247

Group type: EXPERIMENTAL
Intervention: Random practice schedule, 102 trials over three days
Number of subjects: 72

Group type: COMPARATOR
Intervention: Blocked practice schedule, 102 trials over three days
Number of subjects: 72
Study: 10372878

Group type: EXPERIMENTAL
Intervention: Prophylactic macular photocoagulation (argon laser photocoagulation with 12 light spots)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 0
Study: 8558187

Group type: EXPERIMENTAL
Intervention: VM26 120 mg/m2 on days 1, 3, and 5 with cisplatin 80 mg/m2 on day 1
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: VM26 360 mg/m2 on day 1 with cisplatin 80 mg/m2 on day 1
Number of subjects: 225

Group type: COMPARATOR
Intervention: VM26 120 mg/m2 on days 1, 3, and 5 without cisplatin
Number of subjects: 225

Group type: COMPARATOR
Intervention: VM26 360 mg/m2 on day 1 without cisplatin
Number of subjects: 225
Study: 1816217

Group type: EXPERIMENTAL
Intervention: Misoprostol 200 micrograms thrice daily
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 7153940

Group type: EXPERIMENTAL
Intervention: Biofeedback training
Number of subjects: 4
Study: 30294826

Group type: EXPERIMENTAL
Intervention: Oral health therapist intervention (OHTI)
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: Nurse-led intervention (NI)
Number of subjects: 359

Group type: COMPARATOR
Intervention: Pre-intervention (PI)
Number of subjects: 359
Study: 27562361

Group type: EXPERIMENTAL
Intervention: Wearing particulate-filtering respirators
Number of subjects: 24
Study: 25557228

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (2 mg·kg(‐1))
Number of subjects: 28

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 28
Study: 24424704

Group type: EXPERIMENTAL
Intervention: ZST 1.75 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ZST 3.5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ZST
Number of subjects: 0
Study: 22947342

Group type: EXPERIMENTAL
Intervention: Health education intervention including measuring daily salt content, estimating 24-hour salt intake, and cooking classes with less salt
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Health education intervention
Number of subjects: 800

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 800
Study: 19540517

Group type: EXPERIMENTAL
Intervention: Swaddling
Number of subjects: 27
Study: 17047975

Group type: EXPERIMENTAL
Intervention: Tibolone for 6 months
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 77
Study: 10878647

Group type: EXPERIMENTAL
Intervention: Nutritional status measured by anthropometry (Z-scores of height-for-age, weight-for-height, and weight-for-age)
Number of subjects: 28753

Group type: EXPERIMENTAL
Intervention: Nutritional status measured by W/A and W/H
Number of subjects: 28753
Study: 9023841

Group type: EXPERIMENTAL
Intervention: Cisplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drug combinations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combination chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 0
Study: 1444723

Group type: EXPERIMENTAL
Intervention: Clomipramine hydrochloride
Number of subjects: 55
Study: 3901821

Group type: EXPERIMENTAL
Intervention: Ciramadol 60 mg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Ciramadol 30 mg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Morphine 10 mg
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Active therapies (Ciramadol and Morphine)
Number of subjects: 160
Study: 30430273

Group type: EXPERIMENTAL
Intervention: Accurate clinical information
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: No clinical information
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Inaccurate clinical information
Number of subjects: 115

Group type: COMPARATOR
Intervention: Inaccurate clinical information (no hernia on physical exam)
Number of subjects: 115

Group type: COMPARATOR
Intervention: No clinical information (with hernia on physical exam)
Number of subjects: 115